These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12707937)

  • 21. The gene encoding nicastrin, a major gamma-secretase component, modifies risk for familial early-onset Alzheimer disease in a Dutch population-based sample.
    Dermaut B; Theuns J; Sleegers K; Hasegawa H; Van den Broeck M; Vennekens K; Corsmit E; St George-Hyslop P; Cruts M; van Duijn CM; Van Broeckhoven C
    Am J Hum Genet; 2002 Jun; 70(6):1568-74. PubMed ID: 11992262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
    Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BACE2, as a novel APP theta-secretase, is not responsible for the pathogenesis of Alzheimer's disease in Down syndrome.
    Sun X; He G; Song W
    FASEB J; 2006 Jul; 20(9):1369-76. PubMed ID: 16816112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein expression of BACE1, BACE2 and APP in Down syndrome brains.
    Cheon MS; Dierssen M; Kim SH; Lubec G
    Amino Acids; 2008 Aug; 35(2):339-43. PubMed ID: 18163181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.
    Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W
    Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of apolipoprotein E genotype on expression of an autosomal dominant schizophreniform disorder with progressive dementia and neurofibrillary tangles.
    Tsuang D; Raskind MA; Leverenz J; Peskind ER; Schellenberg G; Bird TD
    Biol Psychiatry; 1997 Jan; 41(2):191-5. PubMed ID: 9018389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis.
    Zhao J; Fu Y; Yasvoina M; Shao P; Hitt B; O'Connor T; Logan S; Maus E; Citron M; Berry R; Binder L; Vassar R
    J Neurosci; 2007 Apr; 27(14):3639-49. PubMed ID: 17409228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin-degrading enzyme and Alzheimer disease: a genetic association study in the Han Chinese.
    Bian L; Yang JD; Guo TW; Sun Y; Duan SW; Chen WY; Pan YX; Feng GY; He L
    Neurology; 2004 Jul; 63(2):241-5. PubMed ID: 15277615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of APOE polymorphisms in late-onset dementias.
    Corder EH; Lannfelt L; Bogdanovic N; Fratiglioni L; Mori H
    Cell Mol Life Sci; 1998 Sep; 54(9):928-34. PubMed ID: 9791536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The BACE1-Specific DNA Aptamer A1 Rescues Amyloid-β Pathology and Behavioral Deficits in a Mouse Model of Alzheimer's Disease.
    Liang ZM; Peng YH; Chen Y; Long LL; Luo HJ; Chen YJ; Liang YL; Tian YH; Li SJ; Shi YS; Zhang XM
    Nucleic Acid Ther; 2019 Dec; 29(6):359-366. PubMed ID: 31513457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma amyloid β levels are driven by genetic variants near APOE, BACE1, APP, PSEN2: A genome-wide association study in over 12,000 non-demented participants.
    Damotte V; van der Lee SJ; Chouraki V; Grenier-Boley B; Simino J; Adams H; Tosto G; White C; Terzikhan N; Cruchaga C; Knol MJ; Li S; Schraen S; Grove ML; Satizabal C; Amin N; Berr C; Younkin S; ; Gottesman RF; Buée L; Beiser A; Knopman DS; Uitterlinden A; DeCarli C; Bressler J; DeStefano A; Dartigues JF; Yang Q; Boerwinkle E; Tzourio C; Fornage M; Ikram MA; Amouyel P; de Jager P; Reitz C; Mosley TH; Lambert JC; Seshadri S; van Duijn CM
    Alzheimers Dement; 2021 Oct; 17(10):1663-1674. PubMed ID: 34002480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. APP and BACE1 miRNA genetic variability has no major role in risk for Alzheimer disease.
    Bettens K; Brouwers N; Engelborghs S; Van Miegroet H; De Deyn PP; Theuns J; Sleegers K; Van Broeckhoven C
    Hum Mutat; 2009 Aug; 30(8):1207-13. PubMed ID: 19462468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between the polymorphism in exon 5 of BACE1 gene and Alzheimer's disease.
    Wang M; Yang J; Su J
    Aging Clin Exp Res; 2017 Apr; 29(2):105-113. PubMed ID: 26846559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Apolipoprotein E gene polymorphisms and Alzheimer disease].
    Chen D; Zhang JW; Zhang ZX; Zhao HL; Li XQ; Wu YN; Qu QM
    Yi Chuan Xue Bao; 2003 Dec; 30(12):1167-70. PubMed ID: 14986436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The apolipoprotein E epsilon 4 allele in Parkinson's disease with Alzheimer lesions.
    Egensperger R; Bancher C; Kösel S; Jellinger K; Mehraein P; Graeber MB
    Biochem Biophys Res Commun; 1996 Jul; 224(2):484-6. PubMed ID: 8702415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional domains of the BACE1 and BACE2 promoters and mechanisms of transcriptional suppression of the BACE2 promoter in normal neuronal cells.
    Lahiri DK; Maloney B; Ge YW
    J Mol Neurosci; 2006; 29(1):65-80. PubMed ID: 16757811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein E polymorphism and Alzheimer's disease.
    Poirier J; Davignon J; Bouthillier D; Kogan S; Bertrand P; Gauthier S
    Lancet; 1993 Sep; 342(8873):697-9. PubMed ID: 8103819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of evidence to support the association of polymorphisms within the alpha- and beta-secretase genes (ADAM10/BACE1) with Alzheimer's disease.
    Laws SM; Eckart K; Friedrich P; Kurz A; Förstl H; Riemenschneider M
    Neurobiol Aging; 2011 Mar; 32(3):541-3. PubMed ID: 19344981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BACE2 degradation mediated by the macroautophagy-lysosome pathway.
    Liu X; Wang Z; Wu Y; Wang J; Song W
    Eur J Neurosci; 2013 Jun; 37(12):1970-7. PubMed ID: 23773066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease.
    Cui T; Zhou X; Jin W; Zheng F; Cao X
    Chin Med J (Engl); 2000 Apr; 113(4):340-4. PubMed ID: 11775232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.